HP
ABBV icon

HealthInvest Partners’s AbbVie ABBV Stock Holding History

HealthInvest Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Sell
64,325
-43,856
-41% -$9.44M 4.35% 4
2026
Q1 		$10.4M Hold
108,181
– – 3.35% 8
2025
Q4 		$24.7M Buy
108,181
+16,076
+17% +$3.66M 7.89% 2
2025
Q3 		$2.26M Buy
92,105
+5,172
+6% +$1.05M 8.4% 2
2025
Q2 		$16.1M Sell
86,933
-2,294
-3% -$426K 6.91% 2
2025
Q1 		$18.7M Sell
89,227
-1,496
-2% -$291K 8.25% 2
2024
Q4 		$16M Buy
90,723
+46,237
+104% +$8.5M 7.58% 3
2024
Q3 		$8.79M Buy
44,486
+8,868
+25% +$1.66M 4.13% 7
2024
Q2 		$6.11M Buy
35,618
+6,272
+21% +$1.04M 3.73% 11
2024
Q1 		$5.34M Buy
29,346
+8,150
+38% +$1.4M 3.25% 9
2023
Q4 		$3.28M Buy
+21,196
New +$3.09M 2.57% 19
2022
Q4 		$131K Buy
+811
New +$124K 0.25% 12
2022
Q1 		– Sell
-48,000
Closed -$6.5M – 13
2021
Q4 		$6.5M Buy
48,000
+33,000
+220% +$3.9M 9.16% 4
2021
Q3 		$1.62M Sell
15,000
-70,000
-82% -$8M 2.42% 13
2021
Q2 		$9.57M Buy
85,000
+16,000
+23% +$1.8M 9.07% 9
2021
Q1 		$7.47M Sell
69,000
-18,000
-21% -$1.93M 5.95% 8
2020
Q4 		$9.32M Buy
+87,000
New +$8.36M 6.17% 8

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HealthInvest Partners's ABBV Position: Q2 2026 in Review

HealthInvest Partners reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $9.44M and leaving 64,325 shares worth $16.2M. The position accounts for 4.35% of the portfolio, ranked #4.

HealthInvest Partners first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $24.7M in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HealthInvest Partners held 64,325 shares of AbbVie worth $16.2M as of Q2 2026.
  • HealthInvest Partners sold 43,856 AbbVie shares in Q2 2026, an estimated $9.44M.
  • AbbVie made up 4.35% of HealthInvest Partners's portfolio in Q2 2026, its #4 holding.
  • HealthInvest Partners first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
  • HealthInvest Partners's AbbVie position peaked at $24.7M in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.